Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMA: High Dose Primaquine for P. vivax Prevention
NCT03916003Phase 4Completed
- Sponsor
- Menzies School of Health Research
- Start
- Aug 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of primaquine in Plasmodium vivax malaria, sponsored by Menzies School of Health Research. Started Aug 2019; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT03916003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03916003.